Zobrazeno 1 - 10
of 207
pro vyhledávání: '"Lm, Pilarski"'
Autor:
Federica Gemignani, Adriana Plesa, Roberto Barale, Sean V. Tavtigian, Ilaria Bellini, Charles Dumontet, J Troncy, Troy Perry, Tony Reiman, Lm Pilarski, Stefano Landi
Publikováno v:
Bone Marrow Transplantation. 45:1316-1324
High-dose melphalan (HDM) is an essential component in the treatment of patients with multiple myeloma (MM). Few data are available regarding genetic polymorphisms associated with patient outcome or toxicity in this setting. To identify such polymorp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ca1b4a8df3b148d730a9a6530bbfce4
https://doi.org/10.1038/bmt.2009.335
https://doi.org/10.1038/bmt.2009.335
Autor:
LM Pilarski, Judy A. Beeler, Donald W. Spady, Henry F. Pabst, Mary M. Carson, Margaret P. Krezolek
Publikováno v:
Acta paediatrica (Oslo, Norway : 1992). 86(12)
Spontaneous integrin expression on CD4+, CD8+ and CD19+ lymphocytes at 6 months was significantly lower in breastfed than formula-fed infants (p < 0.05). In another study of 59 formula-fed and 64 breastfed 12-month-old children blast transformation a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a22d6c61735a5136c08ff823251ef54
https://pubmed.ncbi.nlm.nih.gov/9475303
https://pubmed.ncbi.nlm.nih.gov/9475303
Publikováno v:
Blood. 81(2)
Migration through extracellular matrix is fundamental to malignant invasion. A receptor for hyaluronan-mediated motility (RHAMM) has previously been shown to play a fundamental role in locomotion of ras- transformed cells as well as functioning in si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9263068b81440c8d280e765d387c901d
https://pubmed.ncbi.nlm.nih.gov/7678518
https://pubmed.ncbi.nlm.nih.gov/7678518
Publikováno v:
Blood. 66(2)
Although multiple myeloma is a disease of plasma cells, abnormalities have been detected in both B and T lymphocytes in peripheral blood. Although multiple myeloma patients are deficient in surface Ig (sIg)- positive B lymphocytes, analysis of lympho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1748723d7ad4a764ccfac04b5cbe51e6
https://pubmed.ncbi.nlm.nih.gov/3893567
https://pubmed.ncbi.nlm.nih.gov/3893567
Publikováno v:
Blood. 74(6)
The thymus is a site of active T-lymphoid cell proliferation and DNA synthesis. In this study, the capacity of human thymocytes for nucleoside transport was assessed both by cytosine arabinoside influx and by equilibrium binding of nitrobenzylmercapt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c20ba9206cc74342d1ec0da148704e8d
https://pubmed.ncbi.nlm.nih.gov/2529924
https://pubmed.ncbi.nlm.nih.gov/2529924
Publikováno v:
Europe PubMed Central
In multiple myeloma (MM), the VDJ rearrangement of the immunoglobulin heavy chain expressed by MM plasma cells provides a unique clonotypic marker. Although clonotypic MM cells have been found in the circulation, their number has been controversial.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ccc99d1ed9c91b4b45b62ff24bae5475
http://europepmc.org/abstract/med/9763569
http://europepmc.org/abstract/med/9763569
Publikováno v:
Europe PubMed Central
DNA aneuploidy characterizes a proportion of malignant bone marrow (BM)-localized plasma cells in multiple myeloma (MM). This analysis shows that for most MM patients, circulating clonotypic B cells in MM are also hyperdiploid. Although all normal B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b92f4740eb99320fcbf87a8b377b9aab
http://europepmc.org/abstract/med/10690543
http://europepmc.org/abstract/med/10690543
Autor:
Sp, Treon, Ja, Mollick, Urashima M, Teoh G, Chauhan D, Atsushi Ogata, Raje N, Jh, Hilgers, Nadler L, Ar, Belch, Lm, Pilarski, Kc, Anderson
Publikováno v:
Europe PubMed Central
Monoclonal antibodies (MoAbs) that selectively identify Muc-1 core protein (MoAbs DF3-P, VU-4H5) determinants were used to identify the Muc-1 glycoform present on 7 multiple myeloma (MM) cell lines, 5 MM patient plasma cells, 12 MM patient B cells, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::af9144dca6b314dfe7f62fed68ffed98
http://europepmc.org/abstract/med/9949172
http://europepmc.org/abstract/med/9949172
Publikováno v:
Europe PubMed Central
Peripheral blood mononuclear cells (PBMC) from patients with multiple myeloma (MM) are here shown to include 23% +/- 2% of CD34+ cells, the majority of which coexpress CD19, as identified by a panel of 17 anti-CD34 antibodies. The expression of CD34
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::3127420632ab4aba5593aaca745895a0
http://europepmc.org/abstract/med/9057669
http://europepmc.org/abstract/med/9057669
Publikováno v:
Europe PubMed Central
Although chemotherapy effectively reduces the plasma cell burden in multiple myeloma (MM), the disease recurs. MM includes circulating and bone marrow (BM) localized components. A large majority of circulating CD11b+ MM B cells (81%) express an IgH V
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::fca8f0e99b90ff4b89881d3a6028dc85
http://europepmc.org/abstract/med/9345062
http://europepmc.org/abstract/med/9345062